INTRODUCTION
Twenty-six years ago I had the honor to present the Seventh Edgar Allen Memorial Lecture at this University and I am privileged today to be here again to help celebrate another milestone in the history of Yale University and its contributions to cancer research.
On that earlier occasion I had the temerity to speak on "Ten years of Cancer Research." In a similar vein, today I would have to admit to "Forty years of Cancer Research," but I no longer feel justified in trying to recount all the adventures and misadventures covered in that time span. Instead I have chosen to focus on "Initiation and Promotion in Cancer Formation," which might be subtitled "The Importance of Studies on Intercellular Communication," because, in the framework of this symposium, this is where I think much attention should be focused in "The Decade Ahead." 367
For some years I have believed that the three major theories on the nature of cancer could be integrated into a single conceptual framework. According to these theories, which have been considered as mutually exclusive, cancer is caused by somatic mutations, by viruses, or by faulty differentiation. At the center is the somatic mutation theory, formerly incompatible with the virus theory and bitterly opposed by Peyton Rous [1] . Today the virus theory is no longer incompatible with the somatic mutation theory because it is comprehended in terms of altered DNA structures, following the brilliant intuition by Howard Temin and the subsequent experiments by Temin and by Baltimore [ 1] .
The third remaining theory is that cancer is merely a case of faulty differentiation, but it is always implied that this is without altered DNA structures, i.e., without somatic mutation [2] . I disagree with this view. I believe that cancer is indeed a case of faulty differentiation, or, as I phrase it, "Oncogeny is blocked or partially blocked Ontogeny" [3] . In contrast to the usual inference, however, I prefer the hypothesis that the faulty differentiation results from alterations in DNA structure, i.e., either somatic mutations in the usual sense, or by viral modifications of the genome, operationally equivalent to mutations.
Thus the three major theories to explain cancer would all be integrated into a single framework in which faulty differentiation is coupled with either one of the two others. This concept can be further elaborated in terms of failures in the normal intercellular communication that involves positive and negative feedback between differentiated cells acting on their less differentiated precursor or stem cells, as I will indicate.
The idea of faulty differentiation leading to breakdown in intercellular communication is presently being illuminated by basic science advances in the understanding of the phenomena of initiation and promotion, which I shall report today. My major conclusion will be that promoters cause activation of genes for growth factors in normal and initiated cells by derepression. This derepression is brought about by blocking the formation, transmission, or reception of repressors (i.e., inhibitors or chalones [4] ). Repressors normally act between differentiated cells and cells that are capable of dividing, in order to control proliferation.
I will begin by discussing the concepts of initiation and promotion, which have by now received acceptance by many cancer investigators [5] . Promoters are not carcinogens. At the outset it is important to make clear what we mean by the words promoter, initiator, and carcinogen. In order to be effective as a carcinogen in the usual type of laboratory test, a compound almost certainly acts both as an initiator and as a promoter. On the other hand, at very small ("subcarcinogenic") doses, the so-called "complete" carcinogens can act more like "pure initiators," and will not produce tumors when the usual numbers of animals are employed. Thus in the absence of promotion the dose-response at low levels of a carcinogen should exhibit a threshold effect, because the dose may be too low to elicit promotion and therefore too low to produce cancers. In contrast, when higher doses are applied continuously in diets or in skin painting procedures, promotion as well as initiation occurs and cancers result. My own recent work, as yet unpublished, has dealt with the induction of liver tumors in rats with low doses of a known carcinogen in the presence and absence of a known promoter.
Initiators, or the initiating aspects of complete carcinogens, cause alterations in DNA structure and are mutagenic by virtue of their reactivity as electrophiles or after being metabolized to an electrophilic form, according to the well-known work of James and Elizabeth Miller [6] . Sporn and Newton have recently commented that "classical strong 'carcinogens'. . . all of which are known to damage DNA and to be highly mutagenic, may be postulated to have the ability to inactivate the genes that normally repress the synthesis of transforming proteins, and thus to activate synthesis of transforming proteins in an irreversible manner" [7] . In other words, they would regard transformation as a derepression that results from a mutation.
Promoters do not damage DNA and are not mutagenic. However, they do affect phenotypic gene expression and favor cell proliferation so long as they are present [8] . Promoters have been shown to affect cell differentiation [9] and to block intercellular communication [10, 11, 12] , of which more will be said later. It is proposed here that promoter action includes the derepression of initiated cells by virtue of the action of the promoter on normal cells, which may decrease the output of chalones or increase the output of growth factors.
The concepts of initiation and promotion are validated in the final analysis by the fact that the phenomena of "pure initiation" and "pure promotion" have been documented (see below). It seems undesirable to call promoters carcinogens and then use the label as evidence [12] that there are exceptions to the expanding generalization [6] that carcinogens are electrophiles and damage DNA.
Thus neither initiators nor promoters are carcinogens. Acting alone they do not produce cancer, or we may say produce cancer at a very low probability. In contrast, while acting together in proper sequence, they can produce cancer in nearly 100 percent of animals, using relatively small experimental groups, e.g., 20 to 30 animals. We thus pose a problem for basic science and a hypothesis upon which to proceed.
Problem: How to explain extremely low cancer probability by initiators or promoters acting alone and high probability when acting in appropriate sequence?
Hypothesis (in simplest form): Cancer results from two or more relevant mutations: Promoters enhance proliferation of cells with one relevant mutation; this increases the probability of obtaining one cell with two relevant mutations.
The development of this hypothesis will be the purpose of this lecture. Relevant literature on the two-hit or multiple-hit mutation theory of cancer is available [1, [13] [14] [15] [16] . Bell [17] has commented "it is possible that the action of the 'promoter' is simply to expand the mutant clone to a critical size." My hypothesis combines these ideas.
Models for Demonstrating Initiation and Promotion
The experiments that have defined the concept of initiation and promotion were begun by Berenblum, who studied the production of skin tumors in mice [18] . However, the methodology has been extensively refined and extended by R.K. Boutwell of the McArdle Laboratory, who has gone on to explain tumor promotion as gene activation [ 19] . Figure 1 is taken from a recent report by Boutwell [20] since it describes the classic example of initiation and promotion. It will be noted that no tumors in mouse skin result when only initiator is applied, or only the promoter, or when the sequence is reversed or when promoter is not applied at an appropriate frequency. However, when a single application of initiator is followed by applications of promoter at suitable frequency many skin tumors result. In these experiments the number of mice with tumors is nearly 100 percent when both initiation and promotion occurred. Cuyler Hammond expressed a theory of carcinogenesis that is almost a paraphrase of the initiation-promotion concept [24] as presented in this paper. Hammond regarded the cells with atypical nuclei to be genetic variants ("I will assume them to be such" he said [24] [25] at New York University and Carl Peraino et al. [26] at the Argonne Laboratory (Fig. 2 ). Albert fed acetylaminofluorene (AAF) at a variety of levels (0.001, 0.003, 0.01, and 0.03 percent) in the diet for various periods of time (8, 16 , and 32 weeks). In terms of the threshold concept, it is interesting to note that even with 32 weeks of treatment and over 80 weeks of observation, no tumors were seen at the two lower levels of AAF. Tumors were observed after exposure to diets containing 0.01 or 0.03 percent AAF but the incidence was greatly delayed at the lower dietary level, and in fact no tumors were observed when 0.01 percent AAF In terms of the threshold concept, it is not possible to calculate the probability of cancer production at low doses of AAF by using large doses of AAF for longer periods because at the low doses promotion is not present and at the high doses promotion is present. I make this claim because in 1973 Carl Peraino et al. [26] carried out a crucial experiment, also shown in Fig. 2 , in which 0.02 percent AAF was given for only 18 days and then followed by either basal diet or a diet containing 0.05 percent phenobarbital, which most people now believe to act as a promoter of liver carcinogenesis in these experiments [27] . The data in Fig. 2 [26] .
In the experiments by Albert et al. no promoter was used and it is here inferred by comparing the data with that of Peraino et al. that at the lower levels of 2-acetylaminofluorene (AAF) for the shorter periods of time the AAF was ineffective as a promoter. In contrast, in the experiments by Peraino et al. hepatomas were produced by 0.02 percent AAF in the diet for only 18 days when followed by phenobarbital acting as a promoter [26, 27] . Phenobarbital alone produced no hepatomas.
promoter and to inquire whether hepatocarcinomas are produced at these exposures. There Over 100 years later, in 1874, Francesco Durante, an Italian physician, summarized a series of his clinical experiences with the following statement, in which he drew on an analogy that he related to his own clinical experience [29] .
Such elements remain enclosed within well matured tissue for years and years, betraying not the least indication of their presence, until an irritation, a simple stimulus, suffices to rekindle in them movement and cellular activity as is excited by heat within elements of the germinal macula of fowls' eggs ...
Basic Science Origins of the Promoter Concept
In 1974 Boutwell [19] in reviewing the status of the promoter concept noted that, following the observations of John Hill in 1761, Nearly 150 years elapsed before Yamagiwa and Ichikawa in 1915 showed that similar lesions could be produced experimentally by the repeated application of coal tar condensate to the ears of rabbits ... By 1918 Tsutsui had shown that mice were also responsive ... Because the coal tar caused inflammation and wounding these men concluded "The repetition or continuation of chronic irritation may cause cancer" in confirmation of Rudolf Virchow's hypothesis.
Here the point is that when the experimental production of cancer in rabbits and mice with coal tar was first achieved there was no intuition that separated the idea of irritation from the idea of cancer production by chemicals. It took a long time for the isolation of precisely those chemicals that would produce cancer when applied repeatedly in sufficient amounts. The definitive story of their isolation from two tons of coal tar in the 1930s cannot be detailed here but the exact structures were worked out and they could be chemically synthesized. Among them was the aromatic hydrocarbon, 3:4 benzpyrene, which was widely used for the production of skin cancer in mice. An authoritative account of the work by Sir Ernest Kennaway and his collaborators has been published [30] and reference works are available [ In clinical discussion on the relation of irritation to carcinogenesis, there is a tendency to oversimplify the issue by considering only 2 possibilities, either that all irritants are carcinogenic, or that irritation has nothing whatever to do with carcinogenesis.
In the same paper, he reported experiments with a known irritant, croton resin or croton oil, obtained from the croton bean. Although it was some years before the more elegant experiments were carried out [19, 20] , Berenblum stated the problem quite clearly:
Was it possible that among [irritants] there were some which, without being themselves carcinogenic, could augment the tumor-producing action of a carcinogenic agent when the degree of irritation by the latter was insufficient?
Berenblum used the word cocarcinogen and originally used a carcinogen and croton oil together. Meanwhile other experimenters used drastic methods to induce wound healing in areas pretreated with a carcinogen. Thus Peyton Rous and coworkers used cork borers to punch holes in pretreated rabbit ears and observed increased cancer formation on the healing margins. They wrote the first paper with the words initiation and promotion in the title [32] [ 19, 20] . His report included the idea, not fully exploited, that a single application of a subcarcinogenic dose of a carcinogen could be employed to study the effect of a promoter. He wrote as follows:
The combination of croton oil with benzpyrene provides a much more delicate test than the sledge-hammer treatment of continuous painting . .. By its use very short paintings with benzpyrene-even a single painting-sufficed to produce both benign and malignant epidermal tumors. From these early beginnings in 1941 and 1944 it required nine more years for another milestone when it was shown by Salaman and Roe [34] in England that ethyl carbamate (urethane), a very simple compound, can act as a pure initiator of skin cancer in mice.
The object of the present work was to test the hypothesis that there exist also initiating agents which are not carcinogens, at any rate for the tissue under treatment.... It is concluded that urethane is an initiator of carcinogenesis, but not a carcinogen or a co-carcinogen, for mouse skin.
They showed that urethane alone produced no skin tumors. However, when followed by croton oil in multiple treatments many skin tumors resulted.
Their report was almost immediately repeated and confirmed by Berenblum and Haran who reported two years later [35] 
Feedback Control by Differentiated Cells
For some time there has been in the literature a fundamental idea that is the parent of much current research. I have elsewhere [3] referred to it as the Osgood Principle and cited Osgood's efforts at the University of Oregon dating back to 1950 [37, 38] . In 1957 he stated the principle that "with the majority of cell series the homeostatic regulator is an inhibitor of arithmetic cell division and is probably produced by the most chemically mature of the differentiating cells of that series" [37] . The same idea was put forth at about the same time by Weiss and Kavanau [39] and has been extensively discussed by Iversen [40] . I suggest that there are two models for feedback control of cell proliferation. In the first model (Fig. 3) [40] , all of whom emphasized negative feedback. The inclusion of positive feedback in the scheme [3] is based on the recent work of Kurland et al. [41] .
In both models, the cell cycle is shown in the conventional way with M for Mitosis, S for DNA synthetic period, GI for the time gap before S, and G2 for the time gap between S and M. G0 to G0th represents a series of stages in differentiation that are still able to get back to G, and move into the cell cycle. The superscripts A to Nth represent special cell properties that characterize a particular stage and may be transiently expressed. GT (from ref. [3] ) represents a stage of terminal differentiation beyond Go and no longer able to return to GI. "Organism-serving molecules" such as hemoglobin form the link between the terminally differentiated cells and the organism, and the term is preferred to "luxury molecules" [3] .
In Model 11 CSF is for Colony Stimulating Factor, which is a glycoprotein [41] . There appear to be a number of glycoproteins with this function and with different sources and target stem cells. The balance between G, and Go is not fixed but can vary according to the balance between positive and negative feedback factors. The prostaglandin PGE shown in Model 11 is based on a particular cell system [41] and the negative feedback indicated for PGE is not to be generalized, since many other substances perform the chalone function depending on the tissue [40] . from differentiated cells of a different series, e.g., kidney, to the stem cells of a line that gives rise to quite different cells, e.g., in bone marrow. However, this is but a modification of the Osgood Principle, which is shown as model II in Fig. 3 That control of gene expression is a many-splendored thing is illustrated by Fig. 4 . In this figure it may be noted that at least six categories of regulatory sites of action may be specified. Many more could be documented. In examining differentiation at the molecular level it should be recalled that in any given cell only a small fraction of the total genome is available for transcription. Availability of a DNA sequence does not imply that transcription is occurring at the same rate at all times. Thus modulation of phenotypic expression can occur at four levels:
1 It seems likely that in various examples of differentiation the fourth category is involved, while maturation in a cell series may involve only the third category. The Stages of Chemical Carcinogenesis in Liver As a result of current studies in my own laboratory and of work with which I am acquainted I propose a somewhat new scheme of staging categories based on the concepts of initiation and promotion (Fig. 5) 
Stages I and II
The methodology employed is a histochemical stain for demonstrating enzyme action in a thin slice of properly fixed tissue. The method reveals the presence of gamma-glutamyl-transpeptidase (GGT) by the production of a red dye [42] . A slice of normal liver appears almost colorless to the unassisted eye, while microscopic inspection reveals GGT in bile duct epithelium. Our scheme proposes that in Stage I there are numbers of single mutant initiated cells depending on the dose of initiator and the number of susceptible cells. However, these single cells are repressed and held in a non-proliferative state by feedback from adjacent normal cells and possibly by more distant cells. They are virtually impossible to count at the single-cell stage for two reasons: they are difficult to see and identify with certainty, and the probability of hitting any given single cell with only a few slices per liver is very small. The stain for GGT activity is a method for visualizing cells or clones referred to as "enzymealtered foci" always with reference to GGT or whatever other property that can be visualized histochemically. At this date it is still not clear what alterations are necessary for a cell to be quiescent in the absence of a promoter and to proliferate in the presence of a promoter, and the enumeration of GGT-positive foci is taken only as a measure of the ability of a foreign compound to initiate changes that result in proliferation when a promoter is administered.
The reason for postulating the existence of Stage I single mutant repressed nonproliferating cells is based on two lines of collateral research, in addition to the actual observations of the GGT-positive groups of cells seen when phenobarbital is given. First, there is a large and growing literature on the existence of tissue-specific growth suppressors under the name of chalones, for which reports and reviews are available [4, 40, [43] [44] [45] [46] . But more to the point is a new development that deserves considerable attention and further research. In the last week of November 1979 two publications appeared simultaneously, reporting that tumor promoters blocked intercellular communication, thereby strongly supporting the proposition illustrated in Fig. 5 .
One report was from James Trosko and coworkers at Michigan State University [10] and the other was from Murray and Fitzgerald [11] at the University of South Australia, using different cell types and different measurements, but with both groups emphasizing the property of tumor promoters to block intercellular communication. A third report confirming the phenomenon in liver cell monolayers has been made [12] . ROLE Experiments with rat liver have employed acetylaminofluorene (AAF) at low levels for brief periods as an initiator [26, 27] and phenobarbital as a promoter [26, 27] . Enzyme-altered foci have been visualized by a histochemical procedure that reveals gamma-glutamyl transpeptidase (GGT) [42] .
In [3] . The "progression through time" is assumed to involve a second or N + I mutation to yield the cells represented byfilled circles in the chart. This "progression through time" is postulated to occur without the continued presence of a carcinogen or simple initiator and to be the result of single (relevant) mutations that occur spontaneously or as the result of unknown environmental influences. Such single mutations would not result in a neoplasm except when superimposed upon a genome that has already had a relevant mutation. The key to the entire scheme is the idea that a second or N + I mutation with a low probability becomes increasingly probable as the population of first-stage altered cells increases. "Conversion" represents the experimental production of a second step in the initiation process acting on one or more cells in the expanded population of Stage I cells (refer to Table 1 ).
The only way the number of initiated "single-mutant" cells can be estimated is by treating the animal with a promoter or a promoting influence that in my proposal blocks the repression exerted by the normal liver cells. In this situation a clone of from 1,000 to 10,000 cells will develop and form a mass that is readily seen under the microscope. In the case of the larger clones they can be seen on a microscope slide with the unassisted eye. The probability of hitting a clone with a single liver slice depends in a complex way on the size of the clone. Formulae for taking the probabilities into consideration have been worked out and applied by Scherer et al. in Amsterdam [47] . Other methods are being investigated by Dr. H.A. Campbell in connection with experiments referred to earlier (unpublished). After sufficient time has passed many of the clones will have attained a sufficient mass to be able to survive and grow slowly in the absence of the promoter even though subject to fluctuations in host repression. This is Stage II, the critical mass.
The newer techniques for visualizing clones of enzyme-altered cells are very dramatic and there are now at least four different properties that have been visualized [48] [49] [50] [51] . It has been a thrilling experience to look at a liver section and to see masses of altered cells for the first time, using the GGT technique even though subsequent experience has shown that these cells are not necessarily destined to become cancer cells. Work in my laboratory has suggested to me that there may be single mutant cells and clones that cannot be visualized by any of the available techniques, and in fact there can be hepatomas that do not stain for GGT [52] . [48] and by Goldfarb and Pugh [49] . That the phenomenon of regression to what I would call "operationally normal" cells when carcinogen or promoter is withdrawn was suggested by the earlier work of Teebor and Becker [53] and more recently by the work of Gary Williams and coworkers [51, 54] whose tabulated data I have converted to graphic form.
In Fig. 6 are shown the data for the rate of appearance of different sizes of altered enzyme foci as a function of time on a diet containing 0.02 percent AAF, expressed as foci transections per sq cm not corrected for probability of hits (left panel). In the right panel are shown similar data for the disappearance of the altered foci when the animals were placed on a basal diet. It may be seen that nearly all the foci disappeared.
In Fig. 7 further tabulated data from Hirota and Williams [54] are shown graphically. My purpose is to illustrate the change in the numbers of StageI, StageII, Stage III, and Stage V cells with time. With continued exposure to a diet containing 0.02 percent AAF the numbers of enzyme-altered foci transections increased. When the AAF diet was discontinued the numbers dropped sharply by 12 weeks, but the numbers increased somewhat by 24 weeks as critical masses of cells continued to expand and become more likely to be counted. But it is emphasized that the number of altered foci would calculate to thousands per liver as reported by Pitot [56] , while the number of Stage VI nodules was in the range of 0 to 20 per liver and the number of cancers after 48 weeks off the diet was in the range of 0 to 3 per liver. My interpretation of these findings is in terms of Stages I to III for the assumption of the VAN [57] . We propose that the rapidly growing hepatomas have at least one additional mutation and that the numbers shown in Fig. 7 derive from this possibility. Promotion would enhance the possibility of a second mutation because of the increased number of cells with one mutation. In contrast to this route, the probability of a second mutation without promotion is very small because there are vastly fewer cells available for a hit (Fig. 5) .
Thus, the overall scheme (Fig. 5) shows two pathways to the Stage V progressed tumor, or hepatocellular carcinoma in this system. I refer to the low probability pathway in the absence of promotion and the higher probability by a factor of 1,000 or more in the presence of promotion (Table 1 ). In the case of urethane-treated mouse skin, as I mentioned earlier, there were no tumors in the absence of promoter and high incidence in its presence [34, 35] The charts were made by plotting data from Hirota and Williams [49] (with permission from G.M. Williams). The ordinate expresses the number of foci transections per cm2 as noted in Fig. 6 . "Cycles" refers to periods of AAF feeding followed by a period of basal diets as indicated on the abscissa. Groups of animals reveived AAF for three cycles ( * or o ), four cycles ( * or o ), or five cycles ( A or A ). Solid lines represent the time during cycling. Dashed lines represent the time when animals were permanently shifted to basal diet. None of the groups in this chart or Fig. 6 received phenobarbital. In a separate publication Williams and Watanabe [55] reported that when phenobarbital was given in place of basal diet following AAF, the marked decline in foci transections seen in Fig. 6 and Fig. 7 did not occur. experimental fact, never demonstrable before the studies on enzyme-altered foci, that there are thousands of enzyme-altered foci at Stage I even with low doses of AAF, when visualized with the aid of a promoter. Later there are only a few dozen promotion-independent foci as Stage III, and finally there are either no or only a few rapidly growing hepatocelluar carcinomas at Stage V. These numbers are very rough and much further work will be required to improve their accuracy and significance. However, I have used the order of magnitude of these numbers, plus the recent findings of Trosko and others [10, 11, 12] to suggest that promoters act to block the repression of initiated cells by normal cells, thereby leading to their proliferation.
Depending on the degree of proliferation of the first stage cells, the probability of further stages is greatly enhanced. Together the available data appear to support the hypothesis I proposed in the beginning. This hypothesis is based on the vast literature now available regarding the mutational nature of initiation and the non-mutational nature of promotion [58, 59] . Moreover, the phenomenon appears to be applicable to a variety of tumors [56] . Wider appreciation and understanding of the phenomena of initiation and promotion is important because the available data suggest that (1) there may be a low risk of human cancer at levels of carcinogens too low to elicit promotion, and (2) more effort should be made to evaluate the identification and the role of promoting influences in the overall risk of human cancer. Although the 381 _ I am convinced that studies on the molecular mechanisms and practical aspects of initiation and promotion deserve and will get much further attention in the "Decade Ahead."
